Gufic Biosciences Limited (NSE:GUFICBIO)

Gufic Biosciences Revenue

Gufic Biosciences had revenue of 2.61B INR in the quarter ending June 30, 2026, with 16.58% growth. This brings the company's total for the last twelve months to 9.81B, up 16.70% year-over-year. In the fiscal year ending March 31, 2026, Gufic Biosciences had annual revenue of 9.44B with 15.15% growth.

• Revenue (ttm): 9.81B
• Revenue Growth: +16.70%
• P/S Ratio: 4.86
• Revenue / Employee: 6.11M
• Employees: 1,607
• Market Cap: 47.78B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• India 7.27B 77.0%
• Europe 894.19M 9.5%
• Asia 651.82M 6.9%
• North America 320.69M 3.4%
• Africa 268.90M 2.8%
• South America 29.63M 0.3%
• Australia 4.67M 0.0%

Fiscal year ended Mar 31, 2026 See the full Gufic Biosciences breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	9.44B	1.24B	15.15%
Mar 31, 2025	8.20B	131.40M	1.63%
Mar 31, 2024	8.07B	1.16B	16.80%
Mar 31, 2023	6.91B	-885.35M	-11.36%
Mar 31, 2022	7.79B	2.91B	59.76%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error